News Bausch + Lomb Corporation Toronto S.E.

Equities

BLCO

CA0717051076

Market Closed - Toronto S.E. Other stock markets 11:23:02 26/06/2024 pm IST			5-day change	1st Jan Change
20.2 ^CAD	-0.74%		-0.83%	-10.90%

17/06	Bausch + Lomb Brief: To Present New Data at European Dry Eye Society 2024 Congress; Events Include Symposium on Patient-Centric Approaches to Dry Eye, "Highlighting Breakthroughs in Diagnosis, Treatment and Care"	MT
10/06	Bausch + Lomb Corporation Announces the U.S. Introduction of Bausch + Lomb Infuse for Astigmatism Daily Disposable Contact Lenses	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Bausch + Lomb Brief: To Present New Data at European Dry Eye Society 2024 Congress; Events Include Symposium on Patient-Centric Approaches to Dry Eye, "Highlighting Breakthroughs in Diagnosis, Treatment and Care"	17/06	MT
Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress	17/06	BU
Bausch + Lomb Corporation Announces the U.S. Introduction of Bausch + Lomb Infuse for Astigmatism Daily Disposable Contact Lenses	10/06	CI
Bausch + Lomb INFUSE® for Astigmatism Silicone Hydrogel Daily Disposable Contact Lenses Introduced in the United States	10/06	BU
Bausch + Lomb Brief: Launching "Clinically Proven" Nutritional Supplement for Dry Eyes in the United States	03/06	MT
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States	03/06	BU
Bausch + Lomb Corporation Launches Blink? NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States	03/06	CI
Bausch + Lomb Corporation Approves Election of Gary Hu as Director	30/05	CI
Bausch + Lomb Announces 2024 Annual Meeting of Shareholder Results	30/05	BU
Bausch + Lomb Receives Health Canada Approval for enVista Envy Full Visual Range Intraocular Lens	29/05	AQ
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry's Meeting	29/05	AQ
Bausch + Lomb Announces Presentation of New Scientific Data and Evaluations Featuring Consumer, Vision Care and Pharmaceutical Products at Optometry’s Meeting®	28/05	BU
Bausch + Lomb's New Intraocular Lens Approved by Health Canada	28/05	MT
Bausch + Lomb Brief: Says Received Health Canada Approval for Full Visual Range Intraocular Lens	28/05	MT
Bausch + Lomb Receives Health Canada Approval for enVista® Envy™* Full Visual Range Intraocular Lens	28/05	BU
Bausch + Lomb Corporation Receives Health Canada Approval for Envista Envy?? Full Visual Range Intraocular Lens	28/05	CI
Bausch Health Companies - Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024	20/05	AQ
Bausch Health Announces 2024 Annual Meeting of Shareholder Results	16/05	AQ
Bausch + Lomb : 2023 Report	16/05	PU
Bausch + Lomb Shares Rise After Morgan Stanley Upgrade	07/05	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bausch + Lomb Corporation Toronto S.E.

Equities

BLCO

CA0717051076

Summary

Filters